加州乳腺密度法案对筛查性乳腺MR使用、开单医生实践及患者人口学特征的影响
该回顾性研究比较加州乳腺密度法案实施前后30个月内筛查性乳腺MRI的开单模式,以乳腺密度作为检查指征的比例从8.5%(32/376)升至21.1%(136/646,P<.0001),排除高危患者后从8%升至17.2%(P<.0001);患者人口学特征及开单医生特征前后无显著差异。
要点
- 乳腺密度作为筛查MRI指征的比例在法案后由8.5%升至21.1%(P<.0001)。
- 排除高危患者后,该比例仍由8%升至17.2%(P<.0001)。
- 患者种族、族裔及开单医生性别、专科特征前后无显著差异。
核心结论
- 加州乳腺密度法案生效后,非高危女性筛查性乳腺MRI的使用量增加了一倍以上。
- 该法案对MRI使用产生了影响,但其改变结局的临床价值有待进一步研究。
研究设计与样本
- 经机构审查委员会批准的回顾性研究,比较乳腺密度法案实施前后各30个月的筛查性乳腺MRI开单模式。
- 检查按是否将乳腺密度列为检查指征进行亚分类。
- 患者分为高危、高于平均风险(有定义但未量化)以及未定义或平均风险三类。
- 采用χ2检验或Fisher精确检验比较MRI使用、乳腺密度作为指征的使用、患者人口学特征及开单医生特征。
诊断标准与关键数值
- 以乳腺密度为指征的筛查性MRI比例:法案前8.5%(32/376) vs 法案后21.1%(136/646),P<.0001。
- 排除高危患者后,以乳腺密度为指征的比例:法案前8% vs 法案后17.2%,P<.0001。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文结论指出,该法案改变结局的临床价值有待进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the impact of California's Breast Density Law (BDL) on MRI utilization and clinician ordering practices.
MATERIALS AND METHODS: Our institutional review board approved this study that retrospectively compared the ordering pattern for screening breast MRI examinations in the 30-month period before and after the BDL was enacted. Examinations were subcategorized into those with breast density mentioned as an examination indication. Patients were classified into (1) high risk; (2) above average risk, defined but not quantified; and (3) undefined or average risk. χ2 test or Fisher's exact test was used to compare MRI utilization, use of breast density as an indication, patient demographics, and provider characteristics.
RESULTS: Screening MRI examinations with breast density as the indication increased from 8.5% (32 of 376) to 21.1% (136 of 646, P < .0001) after BDL. When high-risk patients were excluded, the increase was from 8% to 17.2% (P < .0001). Patient demographics before and after BDL were, by race: white 71.8% versus 71.2%; Asian 6.4% versus 10.5%; black 3.7% versus 3.1%; American Indian 0.3% versus 1.4%; Native Hawaiian or Pacific Islander 1.6% versus 1.7%; by ethnicity: Hispanic or Latino 10.6% versus 7.9%. Before and after BDL, predominantly female providers (81.4% and 77.4%, P = not significant [NS]) and specialists (62.5% and 63.5%, P = NS) ordered the majority of breast MRI examinations compared with males (18.6% and 22.6%, P = NS).
CONCLUSION: Screening breast MRI utilization for non-high-risk women more than doubled after the California BDL went into effect. BDL has had an impact on MRI utilization, and its clinical value for changing outcomes deserves further study.
引用
- Ram S, Sarma N, López JE, et al. Impact of the California Breast Density Law on Screening Breast MR Utilization, Provider Ordering Practices, and Patient Demographics. J Am Coll Radiol. 2018. PMID: 29622173. doi:10.1016/j.jacr.2017.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。